(CBS News) Sandoz, a subsidiary of pharmaceutical company Novartis, is voluntarily recalling 10 lots of its generic Introvale birth control due to an incorrectly placed placebo pills. The U.S ...

10/30/2007 WILSON , N.C. Sandoz recently completed the major phase of its Wilson, North Carolina expansion when over 50 employees moved into a new 30,000 square foot building.

NEW YORK — Sandoz is developing as many as 10 new follow-on biologics, according to published reports. Reuters, citing an interview with Sandoz head Jeff George in the German newspaper ...

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] ...

Sandoz made its market debut with a lower-than-expected valuation of 10.3 billion Swiss francs ($11.2 billion) on Wednesday, after the generic and biosimilar drugmaker was spun off from Swiss ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% ...

With the announcement this week that Sandoz Inc., a subsidiary of Swiss pharmaceutical company Novartis, will be laying off another 65 employees, the generic drug producer has nearly completed its ...

Sandoz Group AG, the Swiss maker of generic medicines, reported higher revenue in its first report as a listed company, led by growth in biosimilars, which are more complex copycat drugs.. Sales ...

Novartis on Tuesday raised the prospect of divesting its generic drugs unit Sandoz and lifted its peak revenue estimate for its two best-selling pharmaceuticals. ... rose 10% to $4.47 billion, ...

We think Sandoz is in fine financial health. After spinning out from its former parent in October 2023, Sandoz ended its fiscal 2023 with about $1.1 billion in cash and roughly $4.0 billion in ...